Inhaled Molgramostim Granted Fast Track Status for Autoimmune Pulmonary Alveolar Proteinosis
The FDA has granted Fast Track designation to Molgradex (molgramostim; Savara) for the treatment of autoimmune pulmonary alveolar proteinosis.
Miscellaneous Respiratory Disorders
FDA Approves Device That Allows for Reassessment of Lung Transplant Suitability
With Xvivo Perfusion System, surgeons can reassess lungs originally considered unsuitable for transplant
Does Elderberry Supplementation Reduce Upper Respiratory Symptoms?
Elderberry supplementation may reduce the duration and severity of upper respiratory symptoms, according to a meta-analysis published in the journal Complementary Therapies in Medicine.
ATS Issues Practice Guideline for Pediatric Home Oxygen Therapy
Recommendations have been developed for home oxygen therapy in children with chronic respiratory conditions; the clinical practice guideline from the American Thoracic Society was published in the February 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Long-Term Effects of Macrolides in Children With Wheezing
The use of macrolide adjunctive therapy has been shown to be safe and effective for the treatment of children with wheezing disease, according to the results of a systematic review and meta-analysis of randomized controlled trials on the topic.
Drug Combo Tolerated in Younger Children With Cystic Fibrosis
Lumacaftor/ivacaftor safe in children ages 2 to 5 with cystic fibrosis homozygous for F508del-CFTR
FDA Clears Elevo Kit Snoring Intervention Device
The procedure, known as Elevoplasty, was investigated in the S.I.L.E.N.C.E. study (Snoring Intervention via Elevoplasty in a Non-surgical Clinical Environment) which included 52 patients.
Ambient Air Pollution Exposure Linked to Sleep Apnea
The researchers found that 48% of participants had sleep apnea and 25% had a sleep efficiency of ≤88%.
Antibiotics Often Inappropriately Prescribed for Bronchiolitis in ED
Most children younger than 2 years with bronchiolitis seen in US emergency departments and prescribed antibiotics have no documented bacterial coinfection, according to a study published online January 17 in the Journal of the Pediatric Infectious Diseases Society.
Expanding Pharmacist Practice Scope Could Reduce ED Overcrowding
The introduction of emergency department- or community-based pharmacists with an expanded scope of practice may cut emergency department overcrowding, according to a study recently published in Research in Social and Administrative Pharmacy.
